Literature DB >> 31777554

Pneumoperitoneum in laparoscopy and preoperative antihypertensive agents: A retrospective study.

Hyunjee Kim1.   

Abstract

The purpose of the current study was to investigate the effects of preoperative antihypertensive agents on blood pressure (BP) changes after intraperitoneal CO2 insufflation during laparoscopic surgery. The medical records of patients (≥50 years old) undergoing laparoscopic colon surgery were retrospectively analyzed (n=342). The patients were divided into four groups: normotensive group (group N), monotherapy with angiotensin receptor blockers (ARBs) (group A), monotherapy with calcium channel blockers (CCBs) (group C), and combination therapy with ARBs and CCBs (group AC). The systolic BP changes were investigated, and their correlations with preoperative pulse pressure were analyzed. The degree of increase from baseline BP to that after CO2 insufflation was significantly lower in groups A [difference vs. group N, 17.8; 95% confidence interval (CI), 7.8-27.8; P=0.001) and AC (18.2; 95% CI, 8.7-27.7; P<0.001] compared with groups N and C. The incidence of intraoperative hypotension was not significantly different among the groups. In groups A and AC, the preoperative pulse pressure showed a strong correlation (r=0.73 and 0.83, respectively) with the increase in BP after CO2 insufflation. In conclusion, patients with hypertension who received ARBs before surgery showed a strong correlation between the preoperative pulse pressure and BP fluctuation immediately after CO2 insufflation. Small BP fluctuations are suggested to indicate the positive role of ARBs. Large randomized controlled trials are required to validate these results and assess the effect of each antihypertensive agent. This trial was registered (Trial registration: http://www.who.int/ictrp/network/cris2/en/; CRIS; KCT0002595) on the 23 November 2017.
Copyright © 2019, Spandidos Publications.

Entities:  

Keywords:  angiotensin receptor antagonists; antihypertensive agents; hypertension; laparoscopy; pneumoperitoneum; preoperative care

Year:  2019        PMID: 31777554      PMCID: PMC6862321          DOI: 10.3892/etm.2019.8076

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  16 in total

1.  Towards understanding the aetiology and pathophysiology of human hypertension: where are we now?

Authors:  P Kakar; G Y H Lip
Journal:  J Hum Hypertens       Date:  2006-08-24       Impact factor: 3.012

2.  Preoperative Administration of Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers: Do We Have Enough "VISION" to Stop It?

Authors:  Martin J London
Journal:  Anesthesiology       Date:  2017-01       Impact factor: 7.892

3.  2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Lee A Fleisher; Kirsten E Fleischmann; Andrew D Auerbach; Susan A Barnason; Joshua A Beckman; Biykem Bozkurt; Victor G Davila-Roman; Marie D Gerhard-Herman; Thomas A Holly; Garvan C Kane; Joseph E Marine; M Timothy Nelson; Crystal C Spencer; Annemarie Thompson; Henry H Ting; Barry F Uretsky; Duminda N Wijeysundera
Journal:  Circulation       Date:  2014-08-01       Impact factor: 29.690

4.  Terlipressin-ephedrine versus ephedrine to treat hypotension at the induction of anesthesia in patients chronically treated with angiotensin converting-enzyme inhibitors: a prospective, randomized, double-blinded, crossover study.

Authors:  Karoline Meersschaert; Luc Brun; Maximilien Gourdin; Stéphane Mouren; Michèle Bertrand; Bruno Riou; Pierre Coriat
Journal:  Anesth Analg       Date:  2002-04       Impact factor: 5.108

5.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

Authors:  Paul A James; Suzanne Oparil; Barry L Carter; William C Cushman; Cheryl Dennison-Himmelfarb; Joel Handler; Daniel T Lackland; Michael L LeFevre; Thomas D MacKenzie; Olugbenga Ogedegbe; Sidney C Smith; Laura P Svetkey; Sandra J Taler; Raymond R Townsend; Jackson T Wright; Andrew S Narva; Eduardo Ortiz
Journal:  JAMA       Date:  2014-02-05       Impact factor: 56.272

Review 6.  Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors.

Authors:  M E Safar
Journal:  Curr Opin Nephrol Hypertens       Date:  2001-03       Impact factor: 2.894

7.  Combination therapy in hypertension.

Authors:  Alan H Gradman; Jan N Basile; Barry L Carter; George L Bakris; Barry J Materson; Henry R Black; Joseph L Izzo; Suzanne Oparil; Michael A Weber
Journal:  J Am Soc Hypertens       Date:  2010 Mar-Apr

Review 8.  Angiotensin II receptor antagonists.

Authors:  M Burnier; H R Brunner
Journal:  Lancet       Date:  2000-02-19       Impact factor: 79.321

9.  New hypertension guidelines from the National Institute for Health and Clinical Excellence and the British Hypertension Society.

Authors:  Peter Sever
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2006-06       Impact factor: 1.636

10.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redón; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.